These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 15170772)

  • 1. Initial uptake and evidence of safe prescribing practice with Buproprion (Zyban).
    Williams D; Bennett K; Heery A; Feely J
    Pharmacoepidemiol Drug Saf; 2004 Jun; 13(6):411-5. PubMed ID: 15170772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prescribing trends for nicotine replacement therapy in primary care.
    Tilson L; Bennett K; Barry M
    Ir Med J; 2004 Oct; 97(9):270-3. PubMed ID: 15568584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of the introduction of smoke-free legislation on prescribing of stop-smoking medications in England.
    Szatkowski L; Coleman T; McNeill A; Lewis S
    Addiction; 2011 Oct; 106(10):1827-34. PubMed ID: 21561500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Australian smokers' use of bupropion and nicotine replacement therapies and their relation to reimbursement, Australia 2001-05.
    Lutsenko H; Doran CM; Hall WD
    Drug Alcohol Rev; 2008 Mar; 27(2):160-4. PubMed ID: 18264876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Smoking cessation treatment in primary care: prospective cohort study.
    Wilson A; Hippisley-Cox J; Coupland C; Coleman T; Britton J; Barrett S
    Tob Control; 2005 Aug; 14(4):242-6. PubMed ID: 16046686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of the prescribing of potentially inappropriate medications at ambulatory care visits by elderly patients covered by the Taiwanese National Health Insurance program.
    Lai HY; Hwang SJ; Chen YC; Chen TJ; Lin MH; Chen LK
    Clin Ther; 2009 Aug; 31(8):1859-70. PubMed ID: 19808145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GP prescribing of nicotine replacement and bupropion to aid smoking cessation in England and Wales.
    McEwen A; West R; Owen L
    Addiction; 2004 Nov; 99(11):1470-4. PubMed ID: 15500600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pharmacology underlying pharmacotherapy for tobacco dependence: a focus on bupropion.
    Balfour DJ
    Int J Clin Pract; 2001; 55(1):53-7. PubMed ID: 11219320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacotherapy for smoking cessation during pregnancy.
    Benowitz N; Dempsey D
    Nicotine Tob Res; 2004 Apr; 6 Suppl 2():S189-202. PubMed ID: 15203821
    [No Abstract]   [Full Text] [Related]  

  • 10. Suitability of bupropion SR for nicotine-dependent smokers: problems in a practice setting.
    Kohlenberg BS; Antonuccio DO; Hayes SC; Gifford EV; Piasecki MP
    Psychother Psychosom; 2004; 73(4):252-4. PubMed ID: 15184720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bupropion: risks and benefits.
    Ross S; Williams D
    Expert Opin Drug Saf; 2005 Nov; 4(6):995-1003. PubMed ID: 16255659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of bupropion SR for smoking cessation: data from clinical trials and five years of postmarketing experience.
    Ferry L; Johnston JA
    Int J Clin Pract; 2003 Apr; 57(3):224-30. PubMed ID: 12723728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pragmatic, observational study of bupropion treatment for smoking cessation in general practice.
    Wilkes S; Evans A; Henderson M; Gibson J
    Postgrad Med J; 2005 Nov; 81(961):719-22. PubMed ID: 16272237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Safety of Zyban administration in nicotine dependence treatment].
    Goniewicz ML; Czogała J
    Przegl Lek; 2004; 61(10):1200-2. PubMed ID: 15794289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A retrospective survey of the use of bupropion slow release by members of the Canadian Armed Forces.
    Vaillancourt R; Wagenaar H; Fisher C; Conway RD; Plemel J
    Can J Clin Pharmacol; 2002; 9(4):205-13. PubMed ID: 12584579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drugs to support smoking cessation in UK general practice: are evidence based guidelines being followed?
    Wilson A; Sinfield P; Rodgers S; Hammersley V; Coleman T
    Qual Saf Health Care; 2006 Aug; 15(4):284-8. PubMed ID: 16885254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tobacco cessation pharmacotherapy use among First Nations persons residing within British Columbia.
    Wardman AE; Khan N
    Nicotine Tob Res; 2004 Aug; 6(4):689-92. PubMed ID: 15370165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zyban for smoking cessation in a general practice setting: the response to an invitation to make a quit attempt.
    Johnstone E; Hey K; Drury M; Roberts S; Welch S; Walton R; Murphy M
    Addict Biol; 2004; 9(3-4):227-32. PubMed ID: 15511717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spirometry and smoking cessation advice in general practice: a randomised clinical trial.
    Buffels J; Degryse J; Decramer M; Heyrman J
    Respir Med; 2006 Nov; 100(11):2012-7. PubMed ID: 16580189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 12-week double-blind, placebo-controlled study of bupropion sr added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia.
    Evins AE; Cather C; Culhane MA; Birnbaum A; Horowitz J; Hsieh E; Freudenreich O; Henderson DC; Schoenfeld DA; Rigotti NA; Goff DC
    J Clin Psychopharmacol; 2007 Aug; 27(4):380-6. PubMed ID: 17632223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.